Yoseph Aditya 22010110110032 BAB8KTI

(1)

70 1. Alatas H, Tambunan T, Trihono P, Pardede SO. Konsensus Tatalaksana

Sindrom Nefrotik Idiopatik pada Anak. Jakarta. Indonesia:2005.

2. Gbadegesin R, Smoyer WE. Dalam: Denis F, Geary, Franz Schaefer,

penyunting. Comprhensive pediatric nephrology. China: Gearysch mosby;

2008. h.205

3. Lane JC. Nephrotic syndrome [serial online]. 12 Mei 2010 [cited 7 Februari

2014].

Didapat

dari:

www.emedicine.medscape.com/article/9892920-overview

4. Wiguno Prodjosujadi, Divisi Ginjal Hipertensi. Buku Ajar Ilmu Penyakit

Dalam . edisi 4. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam

Fakultas Kedokteran Universitas Indonesia; 2006.

5. Sukandar E, Sulaeman R. Ilmu Penyakit Dalam Jilid II. Jakarta: Balai

Penerbit FKUI;1990. p. 282-305.

6. Orth SR, Ritz E. The Nephrotic Syndrome. N Engl.Med 1998;338:1201-12.

7. Varni J.W., Seid M, Rode C.A. The PedsQL

TM

measurement model for the

pediatric quality of life inventory.PubMed.1999; 37(2):126-39. Available

(2)

71 8. Clark A.G, Barratt T.M. Steroid responsive nephrotic syndrome. Dalam: Pine

J.W., penyunting. Pediatric Nephrology. United States of America: Lippincott

Williams&Wilkins; 1999.h.731-45.

9. Otukesh H, Otukesh S, Mojtahedzadeh M, Hoseini R, Fereshtehnejad S.M.,

Riahi A.F. et.al. Management and outcome of steroid-resistant nephrotic

syndrome in children.2009 [cited 24 Januari 2014]. Available from:

http://translate.google.co.id/translate?hl=id&langpair=en|id&u=http://www.ijk

d.org/index.php/ujkd/article/viewFile/122/129

10. Nachman Patrick H, Jannette Charles J., Falk Ronald J. Primary Glomerular

Disease. In: Brenner, Barry M, editors. The Kidney 8

th

Edition volume 1.

Philadelphia: Saunders Elsevier;2008. p. 1000-03, 1019-28.

11. Wila WIrya IG. Sindrom Nefrotik. Dalam Alatas H, Tambunan T, Trihono P,

Pardede SO. Buku Ajar Nefrologi Anak. Edisi Kedua. Jakarta: Balai Penerbit

FKUI; 2002. h.381-91, 410-22.

12. Appel GB. Glomeruler Disorders and Nephrotic Syndromes. In:Goldman L,

Ausiello

D,eds.Cecil

Medicine.

23

rd

ed.

Philadelphia,

Pa:

Saunders

Elxevier.2007: chap 122.

13. Kumar Vinay, Cotran Ranzi S., Robbins Stanley L. Buku Ajar Patologi

Volume 2. Edisi 7. Jakarta: Penerbit Buku Kedokteran EGC; 2010.

14. Wijaya Indra, Miranti Ika Pawitra. Patologi Ginjal dan Saluran Kemih.

(3)

15. Bahiense, Oliviera M, Saldanha LB, Andrade Mota El, et.al. Primary

Glomerular Disease in Brazil: 1979-1999. Is The Frequency of FSGS

increasing?

Clin Nephrology. 2004;61: 90-7.

16. Kitiyakana C, Eggers P, Kopp JB. 21 year trend in ESRD due to FSGS in The

United States. Am J Kidney Dis. 2004;44: 815-25.

17. Batinic Danko, Milosevic Danko, Coric Marijana, Scukanec-Spoljar Mira,

Konjevoda Pasko, Batinic Danica et.al. Idiopathic nephritic syndrome in

children: review of 282 Croatian cases. Clinical Nephrology. 2012 ;

vol.78-No. 2/2012(116-21). Available from:

www.dustri.com/nc/article

18. Kanemoto Katsuyoshi, Ito Hidekazu, Anzai Michiko, Matsumura Chieko,

Kurayama Hideaki et.al. Clinical significance of IgM and C1q deposition in

the mesangium in pediatric idiopathic nephritic syndrome. JNephrology.

2013; 26(02):306-14. Available from:

www.jnephrol.com/article/clinical-sign

19. D’Agati V. Focal Segmental Glomerulosclerosis. In: D’Agati V, Jannette JC,

Siva FS, eds. Atlas of Non-Tumor Pathology: Nonneoplastic Kidney Disease.

Silver Springer, Md: American Registry of Pathology Brees, 2005: 125-59.

20. Haas M, Maehan S, Karrion TG, Spargo BH. Changing Etiologies of

unexplained adult Nephrotic Syndrome: A Comparison of Renal Biopsy

Finding From 1976-1979 and 1995-1997. Am J Kidney Dis.1997;30:621-31.

21. Aggarwal N, Appel GB. Focal Segmental Glomerulosclerosis. In: Greenberg

A, ed.Primer on Kidney Disease. 5

th

ed., Philadelphia: WB: Saunder;2009:

(4)

73 22. Ahmadzedah A, Derakhsan A, Hakimzadeh M, Zolfigol A. Idiopathic

Nephrotic Syndrome in Iranian Children. Indian Pediatrics 2008; 45;52-3.

23. Nasution A., Aumas P. Gambaran Klinis Laboratorium dan Hasil Pengobatan

Sindrom Nefrotik Pada Anak yang dirawat di bagian IKA RSUP Dr. M.

Djamil Padang periode 1997-2000. Disampaikan pada KONIKA XII Bali:

Ikatan Dokter Anak Indonesia;2001.

24. Nilawati G.A.P. Profil Sindrom Nefrotik pada Ruang Perawatan Anak RSUP

Sanglah Denpasar. Denpasar : Departemen Ilmu Kesehatan Anak Fakultas

Kedokteran Universitas Udayana;2012.

25. NiaudetP. Steroid-sensitive idiopathic nephritic syndrome. Dalam: Avner ED,

Harmon WE, NIaudet P. Pediatric nephrology. Edisi ke-5. Philadelphia:

Lippincott Williams&Wilkins;2004.h.545-73.

26. Okoro BA, Okafur HU. Childhood nephrotic syndrome in Enugu, Nigeria.

(5)

DAFTAR TILIK PENELUSURAN REKAM MEDIK

Tabel 5.

Daftar Tilik Penelusuran Rekam Medik

No.

Keterangan

1. Nama

2. Jenis Kelamin

3. Umur

4. Berat Badan

5. Tinggi Badan

6. Tekanan Darah

<115/75

120-139/80-89

>140/90

7. Kolesterol Total

<200 mg/dl

>200 mg/dl

8. Trigiliserida

9. Protein urin

(-)

(+)1

(+)2

(+)3

(+)4

10. Albumin

<3,5 g/dl

>3,5 g/dl

11. Hematuria

(-)

(+)1

(+)2

(+)3

(+)4

12. Edema

YA

TIDAK

13. Gangguan Lapang

Pandang

YA

TIDAK

14. Infeksi Saluran Napas

Atas

(6)

75

(7)

(8)

(9)

(10)

(11)

Spreadsheet

Data

No.

Jenis

Kelamin

Ggn Lap

Pandang

ISPA

Biopsi

1 L

_110/60

_>200

_150-199

_Tidak

Tidak

FSGS

2 P

_160/90

>200

_>200

Tidak

FSGS

3 L

_115/70

>200

_>200

Tidak

FSGS

4 P

_110/80

>200

_150-199

Tidak

_MN

5 L

_100/60

>200

_>200

Tidak

FSGS

6 P

_120/90

>200

_150-199

Tidak

FSGS

7 P

_110/80

>200

_>200

Tidak

_MN

8 L

_90/60

>200

_150-199

Tidak

_FSGS

9 P

_120/80

>200

_<150

_Ya

Tidak

_MPGN

10 L

_140/100

>200

<150

_Ya

Tidak

_MPGN

11 L

_115/75

>200

<150

_Tidak

_Ya

_MCD

12 P

_150/110

>200

_150-199

_Ya

FSGS

13 P

_100/70

>200

_150-199

Tidak

FSGS

14 P

130/80

>200

<150

Tidak

FSGS

15 L

_114/60

>200

_150-199

Tidak

FSGS

16 L

_160/100

>200

_>200

Tidak

FSGS

17 L

160/100

<200

<150

Tidak

Ya

FSGS

18 P

117/79

>200

150-199

Tidak

FSGS

19 L

110/70

>200

Tidak

FSGS

20 L

110/70

>200

150-199

Ya

Tidak

FSGS

21 P

_110/70

>200

Tidak

_Ya

_MCD

22 P

_100/60

>200

Tidak

_Ya

_MCD

23 L

90/50

>200

150-199

Tidak

FSGS

24 L

_110/70

>200

150-199

Tidak

FSGS

25 L

_90/50

>200

150-199

Tidak

FSGS

26 L

_120/87

>200

₃

Tidak

FSGS

27 L

_100/60

>200

₃

Tidak

_Ya

FSGS

28 P

_90/60

>200

₃

Tidak

FSGS

29 L

_100/60

>200

_<150

Tidak

FSGS

30 L

_120/80

>200

₃

Tidak

FSGS

(12)

(13)

OUTPUT STATISTIK

Analisis Univariat

Statistics

Jenis

Kelamin Umur

Tekanan

Darah Cholesterol TG Prot.Uri

n Albumin Hematuria Edema

Ggn.LapangP

andang ISNA Biopsi

N Valid 31 31 31 31 31 31 31 31 31 31 31 31

Missing 0 0 0 0 0 0 0 0 0 0 0 0

Mean 1.39 1.8710 1.5484 1.9677 2.1935 3.1613 1.0000 .6129 1.0000 .1290 .1935 2.7742

Median 1.00 1.0000 1.0000 2.0000 2.0000 3.0000 1.0000 .0000 1.0000 .0000 .0000 3.0000

Std. Deviation .495 1.28431 1.05952 .17961 .74919 .86011 .00000 1.14535 .00000 .34078 .40161 .71692

Minimum 1 1.00 1.00 1.00 1.00 1.00 1.00 .00 1.00 .00 .00 1.00

Maximum 2 6.00 4.00 2.00 3.00 4.00 1.00 4.00 1.00 1.00 1.00 4.00

Frequency Table

Jenis Kelamin

Frequency Percent Valid Percent

Cumulative

Percent

Valid Laki-Laki 19 61.3 61.3 61.3

(14)

83

Jenis Kelamin

Cumulative

Percent

Valid Laki-Laki 19 61.3 61.3 61.3

Perempuan 12 38.7 38.7 100.0

Total 31 100.0 100.0

Umur

Cumulative

Percent

Valid 1-10 tahun 16 51.6 51.6 51.6

11-20 tahun 10 32.3 32.3 83.9

21-30 tahun 1 3.2 3.2 87.1

31-40 tahun 2 6.5 6.5 93.5

41-50 tahun 1 3.2 3.2 96.8

51-60 tahun 1 3.2 3.2 100.0

Total 31 100.0 100.0

(15)

Cumulative

Percent

Valid 120/80 23 74.2 74.2 74.2

120-139/80-89 3 9.7 9.7 83.9

140-149/90-99 1 3.2 3.2 87.1

>150/100 4 12.9 12.9 100.0

Total 31 100.0 100.0

Cholesterol

Cumulative

Percent

Valid < 200 mg/dl 1 3.2 3.2 3.2

> 200 mg/dl 30 96.8 96.8 100.0

Total 31 100.0 100.0

TG

Cumulative

Percent

Valid <150 mg/dl 6 19.4 19.4 19.4

(16)

85

> 200 mg/dl 12 38.7 38.7 100.0

Total 31 100.0 100.0

Prot.Urin

Cumulative

Percent

Valid +1 2 6.5 6.5 6.5

+2 3 9.7 9.7 16.1

+3 14 45.2 45.2 61.3

+4 12 38.7 38.7 100.0

Total 31 100.0 100.0

Albumin

Cumulative

(17)

Albumin

Cumulative

Percent

Valid < 3,5 g/dl 31 100.0 100.0 100.0

Hematuria

Cumulative

Percent

Valid Negatif 23 74.2 74.2 74.2

+1 1 3.2 3.2 77.4

+2 4 12.9 12.9 90.3

+3 2 6.5 6.5 96.8

+4 1 3.2 3.2 100.0

Total 31 100.0 100.0

Edema

Cumulative

Percent

(18)

87

Ggn.LapangPandang

Cumulative

Percent

Valid Tidak 27 87.1 87.1 87.1

Ya 4 12.9 12.9 100.0

Total 31 100.0 100.0

ISNA

Cumulative

Percent

Valid Tidak 25 80.6 80.6 80.6

Ya 6 19.4 19.4 100.0

Total 31 100.0 100.0

Biopsi

Cumulative

Percent

Valid Minimal Change Disease 3 9.7 9.7 9.7

(19)

Focal Segmental

Glomerulosclerosis

23 74.2 74.2 93.5

Membrano Proliferative

Glomerulonephritis

2 6.5 6.5 100.0

(20)

89 Crosstabs

Case Processing Summary

Cases

Valid Missing Total

N Percent N Percent N Percent

Jenis Kelamin * Biopsi 31 100.0% 0 .0% 31 100.0%

Umur * Biopsi 31 100.0% 0 .0% 31 100.0%

Tekanan Darah * Biopsi 31 100.0% 0 .0% 31 100.0%

Cholesterol * Biopsi 31 100.0% 0 .0% 31 100.0%

TG * Biopsi 31 100.0% 0 .0% 31 100.0%

Prot.Urin * Biopsi 31 100.0% 0 .0% 31 100.0%

Albumin * Biopsi 31 100.0% 0 .0% 31 100.0%

Hematuria * Biopsi 31 100.0% 0 .0% 31 100.0%

Edema * Biopsi 31 100.0% 0 .0% 31 100.0%

Ggn.LapangPandang * Biopsi 31 100.0% 0 .0% 31 100.0%

ISNA * Biopsi 31 100.0% 0 .0% 31 100.0%

(21)

Crosstab

Jenis Kelamin Laki-Laki Count 1 1 16 1 19

% of Total 3.2% 3.2% 51.6% 3.2% 61.3%

Perempuan Count 2 2 7 1 12

% of Total 6.5% 6.5% 22.6% 3.2% 38.7%

Total Count 3 3 23 2 31

% of Total 9.7% 9.7% 74.2% 6.5% 100.0%

Chi-Square Tests

Value df

Asymp. Sig.

(2-sided)

Pearson Chi-Square 2.748a ₃ _.432

Likelihood Ratio 2.703 3 .440

Linear-by-Linear Association 1.388 1 .239

(22)

91

Value df

Asymp. Sig.

(2-sided)

Pearson Chi-Square 2.748a ₃ _.432

N of Valid Cases 31

a. 6 cells (75.0%) have expected count less than 5. The minimum expected

count is .77.

**Umur * Biopsi**

(23)

21-30

Value df

Asymp. Sig.

(2-sided)

Pearson Chi-Square 14.441a 15 .492

(24)

93

N of Valid Cases 31

count is .06.

**Tekanan Darah * Biopsi**

Crosstab

Tekanan Darah 120/80 Count 3 2 17 1 23

(25)

% of

Total

.0% 3.2% 9.7% .0% 12.9%

% of

Total

9.7% 9.7% 74.2% 6.5% 100.0%

Value df

Asymp. Sig.

(2-sided)

Pearson Chi-Square 17.610a ₉ _.040

Linear-by-Linear Association .466 1 .495

N of Valid Cases 31

count is .06.

**Cholesterol * Biopsi**

(26)

95

Cholesterol < 200 mg/dl Count 0 1 0 0 1

% of Total .0% 3.2% .0% .0% 3.2%

> 200 mg/dl Count 3 2 23 2 30

% of Total 9.7% 6.5% 74.2% 6.5% 96.8%

% of Total 9.7% 9.7% 74.2% 6.5% 100.0%

Value df

Asymp. Sig.

(2-sided)

(27)

N of Valid Cases 31

count is .06.

(28)

97

Value df

Asymp. Sig.

(2-sided)

Pearson Chi-Square 12.804a ₆ _.046

N of Valid Cases 31

count is .39.

**Prot.Urin * Biopsi**

(29)

(30)

99

Value df

Asymp. Sig.

(2-sided)

N of Valid Cases 31

count is .13.

**Albumin * Biopsi**

(31)

Total

Count

3

23

2

31 % of

Total

9.7%

74.2%

6.5%

100.0%

Value

Pearson Chi-Square .a

N of Valid Cases 31

a. No statistics are computed because

Albumin is a constant.

**Hematuria * Biopsi**

Crosstab

(32)

101

Value df

Asymp. Sig.

(2-sided)

(33)

N of Valid Cases 31

count is .06.

**Edema * Biopsi**

(34)

103

Value

Pearson Chi-Square .a

N of Valid Cases 31

a. No statistics are computed because

Edema is a constant.

**Ggn.LapangPandang * Biopsi**

Crosstab

Ggn.LapangPandang Tidak Count 3 3 21 0 27

% of Total 9.7% 9.7% 67.7% .0% 87.1%

Ya Count 0 0 2 2 4

% of Total .0% .0% 6.5% 6.5% 12.9%

(35)

Value df

Asymp. Sig.

(2-sided)

N of Valid Cases 31

count is .26.

**ISNA * Biopsi**

(36)

105

% of

Total

9.7%

3.2%

6.5%

.0%

19.4%

Total

Count

3

23

2

31 % of

Total

9.7%

74.2%

6.5%

100.0%

Value df

Asymp. Sig.

(2-sided)

N of Valid Cases 31

(37)